The global drug and gene delivery systems market size is expected to reach around US$ 937 Bn by 2026 and is anticipated to register a CAGR of above 6% from 2019 to 2026.
The report analyzes and forecasts the drug and gene delivery systems market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of drug and gene delivery systems, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major drug and gene delivery systems companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of drug and gene delivery systems upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of drug and gene delivery systems and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global drug and gene delivery systems market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the drug and gene delivery systems market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of drug and gene delivery systems market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
The report also profiles major players operating in the drug and gene delivery systems market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Companies profiled in the report are Oxford BioMedica, Pfizer, Inc., Amgen Inc., Astrazeneca plc, Bayer AG, SiBiono GeneTech Co., Shanghai Sunway Biotech Co., Ltd., Human Stem Cells Institute, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Novartis AG, and Becton, Dickinson and Company.
The drug and gene delivery systems market has been segmented as follows:
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
Section 1 Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
Section 2 Assumptions and Research Methodology
Section 3 Executive Summary
Section 4 Market Overview
4.1. Product Definitions
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3 Opportunities
4.4. Global Drug and Gene Delivery System Market Forecast
4.5. Porter's Five Forces Analysis
4.6. Global Drug and Gene Delivery System Market Outlook
4.7. Technological Advancements in Drug and Gene Delivery Products
4.8. Regulatory Scenario
4.9. Key Mergers & Acquisitions
4.10. Drug and Gene Therapy Pipeline
Section 5 Global Drug and Gene Delivery Systems Market Analysis, by Delivery System
5.1. Key Findings / Developments
5.2. Introduction: Drug Delivery Systems
5.3. Introduction: Gene Delivery Systems
5.4. Introduction & Definitions
5.5. Global Drug and Gene Delivery Systems Market Value Share Analysis, by Drug Delivery System
5.6. Global Drug and Gene Delivery Systems Market Value Share Analysis, by Gene Delivery System
5.7. Global Drug and Gene Delivery Systems Market Forecast, by Drug Delivery System
5.7.1. Intrauterine Implants
5.7.2. Prodrug Implants
5.7.3. Polymeric Drug Delivery
5.7.4. Targeted Drug Delivery
5.8. Global Drug and Gene Delivery Systems Market Forecast, by Gene Delivery System
5.8.1. Viral Gene Delivery
5.8.2. Non-viral Gene Delivery
5.8.3. Combined Hybrid Systems
5.9. Global Drug and Gene Delivery Systems Market Forecast, by Gene Delivery System: Viral Gene Delivery
5.9.1. Adenovirus Vector
5.9.2. Lentivirus Vector
5.9.3. Retrovirus Vector
5.9.4. Adeno-associated Virus Vector
5.9.5. Sendai Virus Vector
5.9.6. Herpes Simplex Virus Vector
5.9.7. Others
5.10. Global Drug and Gene Delivery Systems Market Forecast, by Gene Delivery System: Non-viral Gene Delivery
5.10.1. Natural Organic Compounds
5.10.2. Physical Methods
5.10.3. Chemical Methods
5.11. Global Drug and Gene Delivery Systems Market Analysis, by Drug Delivery System
5.12. Global Drug and Gene Delivery Systems Market Analysis, by Gene Delivery System
5.13. Global Drug and Gene Delivery Systems Market Analysis, by Gene Delivery System: Viral Gene Delivery
5.14. Global Drug and Gene Delivery Systems Market Attractiveness Analysis, by Drug Delivery System
5.15. Global Drug and Gene Delivery Systems Market Attractiveness Analysis, by Gene Delivery System
Section 06 Global Drug and Gene Delivery System Market Analysis, by Application
6.1. Key Findings / Developments
6.2. Introduction & Definitions
6.3. Introduction: Drug Delivery Systems
6.4. Introduction: Gene Delivery Systems
6.5. Global Drug Delivery System Market Value Share Analysis, by Application
6.6. Global Gene Delivery System Market Value Share Analysis, by Application
6.7. Global Drug Delivery System Market Forecast, by Application
6.8.1. Infectious Diseases
6.8.2. Oncology
6.8.3. Ophthalmology
6.8.4. Urology
6.8.5. Diabetes
6.8.6. CNS
6.8.7. Others
6.9. Global Gene Delivery System Market Forecast, by Application
6.9.1. Infectious Diseases
6.9.2. Oncology
6.9.3. Ophthalmology
6.9.4. Urology
6.9.5. Diabetes
6.9.6. CNS
6.9.7. Others
6.10. Global Drug Delivery System Market Attractiveness, by Application
6.11. Global Gene Delivery System Market Attractiveness, by Application
Section 07 Global Drug and Gene Delivery Systems Market Analysis, by Route of Administration
7.1. Key Findings
7.2. Introduction & Definitions
7.3. Introduction: Drug Delivery Systems
7.4. Introduction: Gene Delivery Systems
7.5. Global Drug Delivery Systems Market, by Route of Administration
7.6. Global Gene Delivery Systems Market Value Share Analysis, by Route of Administration
7.7. Global Drug Delivery Systems Market Forecast, by Route of Administration
7.7.1. Oral
7.7.2. Injectable
7.7.3. Inhalation
7.7.4. Transdermal
7.7.5. Ocular
7.7.6. Nasal
7.7.7. Topical
7.8. Global Gene Delivery Systems Market Forecast, by Route of Administration
7.8.1. Oral
7.8.2. Injectable
7.8.3. Inhalation
7.8.4. Transdermal
7.8.5. Ocular
7.8.6. Nasal
7.8.7. Topical
7.9. Global Drug and Gene Delivery Systems Market Attractiveness Analysis, by Drug Delivery: Route of Administration
7.10. Global Drug and Gene Delivery Systems Market Attractiveness Analysis, by Gene Delivery: Route of Administration
Section 08 Global Drug and Gene Delivery Systems Market Analysis, by Region
8.1. Global Drug and Gene Delivery System Market Overview
8.2. Introduction
8.3. Global Drug and Gene Delivery System Market Value Share Analysis, by Region
8.4. Global Drug and Gene Delivery System Market Forecast, by Region
8.4.1. North America
8.4.2. Europe
8.4.3. Asia Pacific
8.4.4. Middle East & Africa
8.4.5. Latin America
8.5. Global Drug and Gene Delivery System Market Attractiveness Analysis, by Region
Section 09 North America Drug and Gene Delivery System Market Analysis
9.1. Key Findings
9.2. North America Drug and Gene Delivery System Market Overview
9.3. North America Drug and Gene Delivery System Market Overview, by Country
9.4. North America Drug and Gene Delivery System Market Value Share Analysis, by Country
9.5. North America Drug Delivery System Market Forecast, by Country
9.5.1. U.S.
9.5.2. Canada
9.6. North America Gene Delivery System Market Forecast, by Country
9.6.1. U.S.
9.6.2. Canada
9.7. North America Drug and Gene Delivery System Market Value Share Analysis, by Delivery System
9.8. North America Drug and Gene Delivery System Market Forecast, by Drug Delivery System
9.8.1. Intrauterine Implants
9.8.2. Prodrug Implants
9.8.3. Polymeric Drug Delivery
9.8.4. Targeted Drug Delivery
9.9. North America Drug and Gene Delivery System Market Forecast, by Gene Delivery System
9.9.1. Viral Gene Delivery
9.9.2. Non-viral Gene Delivery
9.9.3. Combined Hybrid System
9.10. North America Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery
9.11. North America Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery
9.12. North America Gene Delivery System Market Forecast, by Viral Gene Delivery
9.12.1. Adenovirus Vector
9.12.2. Lentivirus Vector
9.12.3. Retrovirus Vector
9.12.4. Adeno-associated Virus Vector
9.12.5. Sendai Virus Vector
9.12.6. Herpes Simplex Virus Vector
9.12.7. Others
9.13. North America Gene Delivery System Market Forecast, by Non-viral Gene Delivery
9.13.1. Natural Organic Compounds
9.13.2. Physical Methods
9.13.3. Chemical Methods
9.14. North America Drug and Gene Delivery System Market Value Share Analysis, by Application
9.15. North America Drug Delivery System Market Forecast, by Application
9.15.1. Infectious Diseases
9.15.2. Oncology
9.15.3. Ophthalmology
9.15.4. Urology
9.15.5. Diabetes
9.15.6. CNS
9.15.7. Others
9.16. North America Gene Delivery System Market Forecast, by Application
9.16.1. Infectious Diseases
9.16.2. Oncology
9.16.3. Ophthalmology
9.16.4. Urology
9.16.5. Diabetes
9.16.6. CNS
9.16.7. Others
9.17. North America Drug and Gene Delivery System Market Value Share Analysis, by Route of Administration
9.18. North America Drug Delivery System Market Forecast, by Route of Administration
9.18.1. Oral
9.18.2. Injectable
9.18.3. Inhalation
9.18.4. Transdermal
9.18.5. Ocular
9.18.6. Nasal
9.18.7. Topical
9.19. North America Gene Delivery System Market Forecast, by Route of Administration
9.20. North America Drug and Gene Delivery System Market Attractiveness Analysis
Section 10 Europe Drug and Gene Delivery System Market Analysis
10.1. Key Findings
10.2. Europe Drug and Gene Delivery System Market Overview
10.3. Europe Drug and Gene Delivery System Market Overview, by Country/Sub-region
10.4. Europe Drug and Gene Delivery System Market Value Share Analysis, by Country/Sub-region
10.5. Europe Drug Delivery System Market Forecast, by Country/Sub-region
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Europe Gene Delivery System Market Forecast, by Country/Sub-region
10.6.1. Germany
10.6.2. U.K.
10.6.3. France
10.6.4. Italy
10.6.5. Spain
10.6.6. Rest of Europe
10.7. Europe Drug and Gene Delivery System Market Value Share Analysis, by Delivery System
10.8. Europe Drug and Gene Delivery System Market Forecast, by Drug Delivery System
10.8.1. Intrauterine Implants
10.8.2. Prodrug Implants
10.8.3. Polymeric Drug Delivery
10.8.4. Targeted Drug Delivery
10.9. Europe Drug and Gene Delivery System Market Forecast, by Gene Delivery System
10.9.1. Viral Gene Delivery
10.9.2. Non-viral Gene Delivery
10.9.3. Combined Hybrid System
10.10. Europe Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery
10.11. Europe Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery
10.12. Europe Gene Delivery System Market Forecast, by Viral Gene Delivery
10.12.1. Adenovirus Vector
10.12.2. Lentivirus Vector
10.12.3. Retrovirus Vector
10.12.4. Adeno-associated Virus Vector
10.12.5. Sendai Virus Vector
10.12.6. Herpes Simplex Virus Vector
10.12.7. Others
10.13. Europe Gene Delivery System Market Forecast, by Non-viral Gene Delivery
10.13.1. Natural Organic Compounds
10.13.2. Physical Methods
10.13.3. Chemical Methods
10.14. Europe Drug and Gene Delivery System Market Value Share Analysis, by Application
10.15. Europe Drug Delivery System Market Forecast, by Application
10.15.1. Infectious Diseases
10.15.2. Oncology
10.15.3. Ophthalmology
10.15.4. Urology
10.15.5. Diabetes
10.15.6. CNS
10.15.7. Others
10.16. Europe Gene Delivery System Market Forecast, by Application
10.16.1. Infectious Diseases
10.16.2. Oncology
10.16.3. Ophthalmology
10.16.4. Urology
10.16.5. Diabetes
10.16.6. CNS
10.16.7. Others
10.17. Europe Drug and Gene Delivery System Market Value Share Analysis, by Route of Administration
10.18. Europe Drug Delivery System Market Forecast, by Route of Administration
10.18.1. Oral
10.18.2. Injectable
10.18.3. Inhalation
10.18.4. Transdermal
10.18.5. Ocular
10.18.6. Nasal
10.18.7. Topical
10.19. Europe Gene Delivery System Market Forecast, by Route of Administration
10.20. Europe Drug and Gene Delivery System Market Attractiveness Analysis
Section 11 Asia Pacific Drug and Gene Delivery System Market Analysis
11.1. Key Findings
11.2. Asia Pacific Drug and Gene Delivery System Market Overview
11.3. Asia Pacific Drug and Gene Delivery System Market Overview, by Country/Sub-region
11.4. Asia Pacific Drug and Gene Delivery System Market Value Share Analysis, by Country/Sub-region
11.5. Asia Pacific Drug Delivery System Market Forecast, by Country/Sub-region
11.5.1. Japan
11.5.2. China
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Asia Pacific Drug Delivery System Market Forecast, by Country/Sub-region
11.6.1. Japan
11.6.2. China
11.6.2. India
11.6.4. Australia & New Zealand
11.6.5. Rest of Asia Pacific
11.7. Asia Pacific Drug and Gene Delivery System Market Value Share Analysis, by Delivery System
11.8. Asia Pacific Drug and Gene Delivery System Market Forecast, by Drug Delivery System
11.8.1. Intrauterine Implants
11.8.2. Prodrug Implants
11.8.3. Polymeric Drug Delivery
11.8.4. Targeted Drug Delivery
11.9. Asia Pacific Drug and Gene Delivery System Market Forecast, by Gene Delivery System
11.9.1. Viral Gene Delivery
11.9.2. Non-viral Gene Delivery
11.9.3. Combined Hybrid System
11.10. Asia Pacific Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery
11.11. Asia Pacific Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery
11.12. Asia Pacific Gene Delivery System Market Forecast, by Viral Gene Delivery
11.12.1. Adenovirus Vector
11.12.2. Lentivirus Vector
11.12.3. Retrovirus Vector
11.12.4. Adeno-associated Virus Vector
11.12.5. Sendai Virus Vector
11.12.6. Herpes Simplex Virus Vector
11.12.7. Others
11.13. Asia Pacific Gene Delivery System Market Forecast, by Non-viral Gene Delivery
11.13.1. Natural Organic Compounds
11.13.2. Physical Methods
11.13.3. Chemical Methods
11.14. Asia Pacific Drug and Gene Delivery System Market Value Share Analysis, by Application
11.15. Asia Pacific Drug Delivery System Market Forecast, by Application
11.15.1. Infectious Diseases
11.15.2. Oncology
11.15.3. Ophthalmology
11.15.4. Urology
11.15.5. Diabetes
11.15.6. CNS
11.15.7. Others
11.16. Asia Pacific Gene Delivery System Market Forecast, by Application
11.16.1. Infectious Diseases
11.16.2. Oncology
11.16.3. Ophthalmology
11.16.4. Urology
11.16.5. Diabetes
11.16.6. CNS
11.16.7. Others
11.17. Asia Pacific Drug and Gene Delivery System Market Value Share Analysis, by Route of Administration
11.18. Asia Pacific Drug Delivery System Market Forecast, by Route of Administration
11.18.1. Oral
11.18.2. Injectable
11.18.3. Inhalation
11.18.4. Transdermal
11.18.5. Ocular
11.18.6. Nasal
11.18.7. Topical
11.19. Asia Pacific Gene Delivery System Market Forecast, by Route of Administration
11.20. Asia Pacific Drug and Gene Delivery System Market Attractiveness Analysis
Section 12 Latin America Drug and Gene Delivery System Market Analysis
12.1. Key Findings
12.2. Latin America Drug and Gene Delivery System Market Overview
12.3. Latin America Drug and Gene Delivery System Market Overview, by Country/Sub-region
12.4. Latin America Drug and Gene Delivery System Market Value Share Analysis, by Country/Sub-region
12.5. Latin America Drug Delivery System Market Forecast, by Country/Sub-region
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Latin America Gene Delivery System Market Forecast, by Country/Sub-region
12.6.1. Brazil
12.6.2. Mexico
12.6.3. Rest of Latin America
12.7. Latin America Drug and Gene Delivery System Market Value Share Analysis, by Delivery System
12.8. Latin America Drug and Gene Delivery System Market Forecast, by Drug Delivery System
12.8.1. Intrauterine Implants
12.8.2. Prodrug Implants
12.8.3. Polymeric Drug Delivery
12.8.4. Targeted Drug Delivery
12.9. Latin America Drug and Gene Delivery System Market Forecast, by Gene Delivery System
12.9.1. Viral Gene Delivery
12.9.2. Non-viral Gene Delivery
12.9.3. Combined Hybrid System
12.10. Latin America Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery
12.11. Latin America Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery
12.12. Latin America Gene Delivery System Market Forecast, by Viral Gene Delivery
12.12.1. Adenovirus Vector
12.12.2. Lentivirus Vector
12.12.3. Retrovirus Vector
12.12.4. Adeno-associated Virus Vector
12.12.5. Sendai Virus Vector
12.12.6. Herpes Simplex Virus Vector
12.12.7. Others
12.13. Latin America Gene Delivery System Market Forecast, by Non-viral Gene Delivery
12.13.1. Natural Organic Compounds
12.13.2. Physical Methods
12.13.3. Chemical Methods
12.14. Latin America Drug and Gene Delivery System Market Value Share Analysis, by Application
12.15. Latin America Drug Delivery System Market Forecast, by Application
12.15.1. Infectious Diseases
12.15.2. Oncology
12.15.3. Ophthalmology
12.15.4. Urology
12.15.5. Diabetes
12.15.6. CNS
12.15.7. Others
12.16. Latin America Gene Delivery System Market Forecast, by Application
12.16.1. Infectious Diseases
12.16.2. Oncology
12.16.3. Ophthalmology
12.16.4. Urology
12.16.5. Diabetes
12.16.6. CNS
12.16.7. Others
12.17. Latin America Drug and Gene Delivery System Market Value Share Analysis, by Route of Administration
12.18. Latin America Drug Delivery System Market Forecast, by Route of Administration
12.18.1. Oral
12.18.2. Injectable
12.18.3. Inhalation
12.18.4. Transdermal
12.18.5. Ocular
12.18.6. Nasal
12.18.7. Topical
12.19. Latin America Gene Delivery System Market Forecast, by Route of Administration
12.20. Latin America Drug and Gene Delivery System Market Attractiveness Analysis
Section 13 Middle East & Africa Drug and Gene Delivery System Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Drug and Gene Delivery System Market Overview
13.3. Middle East & Africa Drug and Gene Delivery System Market Overview, by Country/Sub-region
13.4. Middle East & Africa Drug and Gene Delivery System Market Value Share Analysis, by Country/Sub-region
13.5. Middle East & Africa Drug Delivery System Market Forecast, by Country/Sub-region
13.5.1. GCC
13.5.2. South Africa
13.5.3. Israel
13.5.4. Rest of MEA
13.6. Middle East & Africa Drug Delivery System Market Forecast, by Country/Sub-region
13.6.1. GCC
13.6.2. South Africa
13.6.3. Israel
13.6.4. Rest of MEA
13.7. Middle East & Africa Drug and Gene Delivery System Market Value Share Analysis, by Delivery System
13.8. Middle East & Africa Drug and Gene Delivery System Market Forecast, by Drug Delivery System
13.8.1. Intrauterine Implants
13.8.2. Prodrug Implants
13.8.3. Polymeric Drug Delivery
13.8.4. Targeted Drug Delivery
13.9. Middle East & Africa Drug and Gene Delivery System Market Forecast, by Gene Delivery System
13.9.1. Viral Gene Delivery
13.9.2. Non-viral Gene Delivery
13.9.3. Combined Hybrid System
13.10. Latin America Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery
13.11. Middle East & Africa Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery
13.12. Middle East & Africa Gene Delivery System Market Forecast, by Viral Gene Delivery
13.12.1. Adenovirus Vector
13.12.2. Lentivirus Vector
13.12.3. Retrovirus Vector
13.12.4. Adeno-associated Virus Vector
13.12.5. Sendai Virus Vector
13.12.6. Herpes Simplex Virus Vector
13.12.7. Others
13.13. Middle East & Africa Gene Delivery System Market Forecast, by Non-viral Gene Delivery
13.13.1. Natural Organic Compounds
13.13.2. Physical Methods
13.13.3. Chemical Methods
13.14. Middle East & Africa Drug and Gene Delivery System Market Value Share Analysis, by Application
13.15. Middle East & Africa Drug Delivery System Market Forecast, by Application
13.15.1. Infectious Diseases
13.15.2. Oncology
13.15.3. Ophthalmology
13.15.4. Urology
13.15.5. Diabetes
13.15.6. CNS
13.15.7. Others
13.16. Middle East & Africa Gene Delivery System Market Forecast, by Application
13.16.1. Infectious Diseases
13.16.2. Oncology
13.16.3. Ophthalmology
13.16.4. Urology
13.16.5. Diabetes
13.16.6. CNS
13.16.7. Others
13.17. Middle East & Africa Drug and Gene Delivery System Market Value Share Analysis, by Route of Administration
13.18. Middle East & Africa Drug Delivery System Market Forecast, by Route of Administration
13.18.1. Oral
13.18.2. Injectable
13.18.3. Inhalation
13.18.4. Transdermal
13.18.5. Ocular
13.18.6. Nasal
13.18.7. Topical
13.19. Middle East & Africa Gene Delivery System Market Forecast, by Route of Administration
13.20. Middle East & Africa Drug and Gene Delivery System Market Attractiveness Analysis
Section 14 Competition Landscape
14.1. Competition Matrix
Section 15 Company Profiles
15.1. Novartis AG
15.1.1. Company Description
15.1.2. Financial Overview
15.1.3. Strategy & Recent Developments
15.1.4. SWOT Analysis
15.2. Amgen Inc.
15.2.1. Company Description
15.2.2. Financial Overview
15.2.3. Strategy & Recent Developments
15.2.4. SWOT Analysis
15.3. Oxford BioMedica plc.
15.3.1. Company Description
15.3.2. Financial Overview
15.3.3. Strategy & Recent Developments
15.3.4. SWOT Analysis
15.4. SIBIONO
15.4.1. Company Description
15.4.2. Financial Overview
15.4.3. Strategy & Recent Developments
15.4.4. SWOT Analysis
15.5. Shanghai Sunway Biotech Co., Ltd.
15.5.1. Company Description
15.5.2. Financial Overview
15.5.3. Strategy & Recent Developments
15.5.4. SWOT Analysis
15.6. F. Hoffmann-La Roche Ltd.
15.6.1. Company Description
15.6.2. Financial Overview
15.6.3. Strategy & Recent Developments
15.6.4. SWOT Analysis
15.7. Pfizer, Inc.
15.7.1. Company Description
15.7.2. Financial Overview
15.7.3. Strategy & Recent Developments
15.7.4. SWOT Analysis
15.8. Bayer AG
15.8.1. Company Description
15.8.2. Financial Overview
15.8.3. Strategy & Recent Developments
15.8.4. SWOT Analysis
15.9. Johnson & Johnson Services, Inc.
15.9.1. Company Description
15.9.2. Financial Overview
15.9.3. Strategy & Recent Developments
15.9.4. SWOT Analysis
15.10. Becton, Dickinson and Company
15.10.1. Company Description
15.10.2. Financial Overview
15.10.3. Strategy & Recent Developments
15.10.4. SWOT Analysis
15.11. AstraZeneca plc.
15.11.1. Company Description
15.11.2. Financial Overview
15.11.3. Strategy & Recent Developments
15.11.4. SWOT Analysis
15.12. Baxter International, Inc.
15.12.1. Company Description
15.12.2. Financial Overview
15.12.3. Strategy & Recent Developments
15.12.4. SWOT Analysis
15.13. Human Stem Cells Institute
15.13.1. Company Description
15.13.2. Financial Overview
15.13.3. Strategy & Recent Developments
15.13.4. SWOT Analysis
15.14. Boston Scientific Corporation
15.14.1. Company Description
15.14.2. Financial Overview
15.14.3. Strategy & Recent Developments
15.14.4. SWOT Analysis
15.15. Epeius Biotechnologies Corporation
15.15.1. Company Description
15.15.2. Financial Overview
15.15.3. Strategy & Recent Developments
15.15.4. SWOT Analysis
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers